Small molecules which reverse pancreatic ductal adenocarcinoma
Canned Analysis
FAIR Metrics
0 evaluations
General Information
AccessionDCA00010561
TitleSmall molecules which reverse pancreatic ductal adenocarcinoma
DescriptionThe L1000 database was queried in order to identify small molecule perturbations which reverse the pancreatic ductal adenocarcinoma gene expression signature in the Pancreas (Advanced stage of murine PDAC and Control pancreas) cell type.
Analysis URLhttp://amp.pharm.mssm.edu/L1000CDS2/#/result/58d1b90ae467bea600fb8158
Upload DateSeptember 20, 2017
Uploadermaayanlab
Metadata
Analysis Curatorcadimo
CREEDS IDdz:698
Cell TypePancreas (Advanced stage of murine PDAC and Control pancreas)
DO IDDOID:3498
Disease Namepancreatic ductal adenocarcinoma
Organismmouse
UMLS CUIC1335302
L1000CDS2 parameters
Directionreverse
Characteristic Direction parameters
Control SamplesGSM1504087, GSM1504088, GSM1504089
Perturbed SamplesGSM1504090, GSM1504091, GSM1504092
Tools used in the analysis
Dataset Accession
L1000CDS2
Published August 2016
An ultra-fast LINCS L1000 Characteristic Direction signature search engine
7756
Characteristic Direction
Published March 2014
A geometrical multivariate approach to identify differentially expressed genes
26829
Datasets used in the analysis
Keyword
Tool Name
GSE61412
Gene Expression Omnibus
Expression data from advanced stage of murine pancreatic ductal adenocarcinoma (PDAC) and control pancreas
7
FAIR Evaluation
Sorry, you must be signed in to evaluate this object.